SCHEMBL676233

SCHEMBL676233

CCCC#Cc1ccc2c(c1)c1ccc(Cl)nc1n2S(=O)(=O)c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 2/20 0.34
DCTPP1 Q9H773 1/20 0.34
HTR6 P50406 4/20 0.33
PPARG P37231 3/20 0.33
PPARA Q07869 3/20 0.33
PPARD Q03181 2/20 0.33
PTGDR Q13258 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
PAX8 Q06710 2/20 0.33
MMP13 P45452 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
CNR2 P34972 1/20 0.32
MTNR1B P49286 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL676193 0.87 SRC (0.39) SRCDCTPP1HTR6PPARGPPARA
SCHEMBL675233 0.83 HTR6 (0.36) SRCHTR6PPARGPPARAPPARD
SCHEMBL676265 0.82 PTGDR2 (0.35) DCTPP1HTR6PTGDRPTGDR2PAX8
SCHEMBL3427917 0.81 NPC1 (0.36) PAX8NPC1RAB9A
SCHEMBL676169 0.79 PAX8 (0.40) SRCHTR6PAX8NPC1RAB9A
SCHEMBL675860 0.77 NPC1 (0.46) SRCDCTPP1HTR6NPC1RAB9A
SCHEMBL675280 0.77 HTR6 (0.44) SRCDCTPP1HTR6PPARGPPARA
SCHEMBL3668236 0.77 HTR6 (0.46) SRCHTR6PPARGPPARAPPARD
SCHEMBL674753 0.74 TP53 (0.40) SRCHTR6PPARGPPARAPPARD
SCHEMBL678710 0.74 TP53 (0.40) SRCHTR6PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895744-B2 Alfa-carboline inhibitors of NPM-ALK, RET, and Bcr-Abl UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA (IT) 2014-11-25 US disclosed
US-20110281862-A1 ALFA-CARBOLINE INHIBITORS OF NPM-ALK, RET, AND BCR-ABL UNIVERSITA' DEGLI STUDI DI MILANO - BICOCCA (IT) 2011-11-17 US disclosed
EP-2161271-A1 Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl Università Degli Studi Di Milano - Bicocca (IT) 2010-03-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281862-A1 ALFA-CARBOLINE INHIBITORS OF NPM-ALK, RET, AND BCR-ABL ALK, BCR, NPM1 SRC 178/4885DCTPP1 4813/4885HTR6 4762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.